News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
792,433 Results
Type
Article (61081)
Company Profile (368)
Press Release (730971)
Multimedia
Podcasts (134)
Webinars (19)
Section
Business (218443)
Career Advice (2637)
Deals (37825)
Drug Delivery (144)
Drug Development (86737)
Employer Resources (180)
FDA (17765)
Job Trends (16298)
News (371513)
Policy (36288)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2956)
Accelerated approval (37)
Adcomms (34)
Allergies (153)
Alliances (53698)
ALS (184)
Alzheimer's disease (1788)
Antibody-drug conjugate (ADC) (345)
Approvals (17984)
Artificial intelligence (591)
Autoimmune disease (179)
Automation (44)
Bankruptcy (382)
Best Places to Work (12375)
BIOSECURE Act (21)
Biosimilars (203)
Biotechnology (234)
Bladder cancer (165)
Brain cancer (66)
Breast cancer (675)
Cancer (5123)
Cardiovascular disease (444)
Career advice (2227)
Career pathing (41)
CAR-T (305)
CDC (57)
Celiac Disease (2)
Cell therapy (805)
Cervical cancer (38)
Clinical research (73623)
Collaboration (1856)
Company closure (4)
Compensation (1190)
Complete response letters (73)
COVID-19 (2958)
CRISPR (103)
C-suite (922)
Cystic fibrosis (154)
Data (6463)
Decentralized trials (2)
Denatured (48)
Depression (154)
Diabetes (534)
Diagnostics (7121)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (280)
Drug pricing (215)
Drug shortages (34)
Duchenne muscular dystrophy (243)
Earnings (93790)
Editorial (66)
Employer branding (22)
Employer resources (160)
Events (126238)
Executive appointments (1040)
FDA (21034)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1587)
Gene editing (220)
Generative AI (54)
Gene therapy (659)
GLP-1 (1098)
Government (5178)
Grass and pollen (8)
Guidances (388)
Healthcare (20558)
HIV (66)
Huntington's disease (49)
IgA nephropathy (89)
Immunology and inflammation (293)
Immuno-oncology (65)
Indications (119)
Infectious disease (3258)
Inflammatory bowel disease (211)
Inflation Reduction Act (15)
Influenza (125)
Intellectual property (259)
Interviews (446)
IPO (17497)
IRA (55)
Job creations (4273)
Job search strategy (1860)
JPM (65)
Kidney cancer (18)
Labor market (87)
Layoffs (616)
Leadership (40)
Legal (8893)
Liver cancer (98)
Longevity (17)
Lung cancer (695)
Lymphoma (389)
Machine learning (44)
Management (62)
Manufacturing (864)
MASH (176)
Medical device (14961)
Medtech (15021)
Mergers & acquisitions (21421)
Metabolic disorders (1393)
Multiple sclerosis (172)
NASH (21)
Neurodegenerative disease (358)
Neuropsychiatric disorders (102)
Neuroscience (3135)
Neurotech (1)
NextGen: Class of 2026 (7276)
Non-profit (4991)
Now hiring (68)
Obesity (672)
Opinion (328)
Ovarian cancer (171)
Pain (217)
Pancreatic cancer (242)
Parkinson's disease (301)
Partnered (34)
Patents (525)
Patient recruitment (522)
Peanut (61)
People (63321)
Pharmaceutical (84)
Pharmacy benefit managers (33)
Phase 1 (22867)
Phase 2 (32269)
Phase 3 (24180)
Pipeline (5584)
Policy (322)
Postmarket research (2926)
Preclinical (9885)
Press Release (71)
Prostate cancer (255)
Psychedelics (55)
Radiopharmaceuticals (310)
Rare diseases (949)
Real estate (6630)
Recruiting (73)
Regulatory (26980)
Reports (55)
Research institute (2674)
Resumes & cover letters (424)
Rett syndrome (28)
RNA editing (20)
RSV (87)
Schizophrenia (159)
Series A (264)
Series B (205)
Service/supplier (13)
Sickle cell disease (102)
Special edition (27)
Spinal muscular atrophy (173)
Sponsored (45)
Startups (4137)
State (2)
Stomach cancer (21)
Supply chain (110)
Tariffs (94)
The Weekly (84)
Vaccines (1145)
Venture capital (98)
Weight loss (453)
Women's health (97)
Worklife (21)
Date
Today (153)
Last 7 days (585)
Last 30 days (2462)
Last 365 days (31450)
2026 (4162)
2025 (31754)
2024 (36970)
2023 (41964)
2022 (53282)
2021 (58053)
2020 (56921)
2019 (50272)
2018 (38180)
2017 (35170)
2016 (35387)
2015 (41307)
2014 (35133)
2013 (30601)
2012 (32786)
2011 (33408)
2010 (32057)
Location
Africa (947)
Alabama (86)
Alaska (7)
Arizona (330)
Arkansas (14)
Asia (45069)
Australia (7559)
California (11668)
Canada (3366)
China (1181)
Colorado (497)
Connecticut (512)
Delaware (352)
Europe (100258)
Florida (1735)
Georgia (381)
Hawaii (3)
Idaho (66)
Illinois (946)
India (74)
Indiana (542)
Iowa (23)
Japan (449)
Kansas (132)
Kentucky (42)
Louisiana (27)
Maine (72)
Maryland (1467)
Massachusetts (8511)
Michigan (341)
Minnesota (663)
Mississippi (6)
Missouri (141)
Montana (36)
Nebraska (28)
Nevada (127)
New Hampshire (86)
New Jersey (3122)
New Mexico (31)
New York (3105)
North Carolina (1580)
North Dakota (10)
Northern California (5677)
Ohio (349)
Oklahoma (23)
Oregon (46)
Pennsylvania (2354)
Puerto Rico (25)
Rhode Island (50)
South America (1334)
South Carolina (69)
South Dakota (1)
Southern California (4544)
Tennessee (182)
Texas (1817)
United States (41896)
Utah (349)
Vermont (1)
Virginia (280)
Washington D.C. (85)
Washington State (972)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
792,433 Results for "ra medical systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Landmark RESET-RA Study Published in Nature Medicine Demonstrates Durable Efficacy and Safety of the SetPoint System for Rheumatoid Arthritis
January 5, 2026
·
4 min read
Press Releases
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
February 12, 2026
·
4 min read
Press Releases
Baseline Therapeutics Launches to Advance GLP-1RA Phase 3 Program in Alcohol Use Disorder
January 28, 2026
·
3 min read
Press Releases
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
·
28 min read
Press Releases
Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor
January 29, 2026
·
4 min read
Press Releases
Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC
January 27, 2026
·
8 min read
Press Releases
KORU Medical Systems, Inc. Appoints Eric Schiller as Chief Technology Officer
December 17, 2025
·
3 min read
Press Releases
Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial
February 4, 2026
·
9 min read
Press Releases
Verastem Oncology Provides Preliminary Fourth Quarter and 2025 Revenue and Business Updates and Outlines 2026 Strategic Priorities for Novel Portfolio Targeting RAS/MAPK Pathway-Driven Cancers
February 5, 2026
·
16 min read
Press Releases
Coya Therapeutics Announces That Its Combination LD IL-2/GLP-1 RA Candidate (COYA 303) Demonstrated Potent Systemic and Brain Anti-Inflammatory Efficacy In Vivo
November 5, 2025
·
7 min read
1 of 79,244
Next
